David R Liu

36PUBLICATIONS

279CO-AUTHORS

Gene and molecular therapyMolecular targetsPredictive and prognostic markersInnate immunityCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (36)

Sort by Publication Date:

|May 25, 2026

Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in <i>BRAF</i>-Mutant Melanoma.

|Feb 18, 2026

Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Yubao Wang, Cherubin Manokaran, Yutian Zou

|Dec 31, 2025

Mechanisms of tumor persistence in metastatic melanoma following successful immunotherapy.

Yingxiao Shi, Zoltan Maliga, Tuulia Vallius

|Sep 02, 2025

Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of tolerance.

Koki Hayashi, Takahiro Yokose, Jenna Lancey

|Sep 01, 2025

Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma.

Jiekun Yang, Cassia Wang, Doris Fu

|Jul 22, 2025

Specific oncogene activation of the cell of origin in mucosal melanoma.

Swathy Babu, Jiajia Chen, Chloé S Baron

Pageof 6

Frequent Collaborators

Eliezer Van Allen

Giuseppe Tarantino

Genevieve M Boland

Lynette M Sholl

Yingxiao Shi

Peter K Sorger

Jihye Park

Kenneth L Kehl

Brendan Reardon

Alexander Gusev

Frequent Collaborators

Eliezer Van Allen

Giuseppe Tarantino

Genevieve M Boland

Lynette M Sholl